Patients on the weight-loss drug Zepbound regained weight almost one year after stopping treatment, according to a study published this week in the Journal of the American Medical Association.
Opinions expressed by Forbes Contributors are their own. Dr. Omer Awan is a practicing physician who covers public health. CARLSBAD, CA-NOV 30TH: Mounjaro injection pen on display at Rachel Graham ...
As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scala asked CEO David Ricks if the company ...
Zepbound was more effective than a placebo at reducing the severity of obstructive sleep apnea in patients with obesity after a year ... for Zepbound," even before any changes to the federal ...
More doses of Novo Nordisk’s popular weight loss drug Wegovy are back in stock in the U.S. after years of shortages and just days after all doses of Eli Lilly’s rival injection Zepbound became ...
Noom Med is a new add-on service that provides prescriptions for GLP-1 medications, such as Zepbound, to eligible Noom members to further support their weight loss efforts. After an initial ...